Search Within

Boglarka Gyurkocza

Formats
  1. Meeting Abstract (91)
  2. Journal Article (39)
  3. Research Letter (7)
  4. Review (1)
Groups
  1. Bone Marrow Transplant (138)
  2. Center for Hematologic Malignancies (138)
  3. Department of Medicine (138)
  4. Hematologic Malignancies, Division of (138)
  5. Survivorship Research (138)
  6. CTCR Scholars (104)

More Groups

People
  1. Sergio Giralt (117)
  2. Miguel-Angel Perales (97)
  3. Roni Tamari (80)
  4. Brian Shaffer (79)
  5. Esperanza Papadopoulos (77)
  6. Sean Devlin (72)

More People

Years
  1. 2025 (3)
  2. 2024 (7)
  3. 2023 (20)
  4. 2022 (14)
  5. 2021 (10)
  6. 2020 (21)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (40)
  2. Blood (40)
  3. Bone Marrow Transplantation (13)
  4. Blood Advances (9)
  5. Transplantation and Cellular Therapy (9)
  6. Clinical Lymphoma, Myeloma and Leukemia (4)

More Publications

Publishers
  1. Elsevier Inc. (53)
  2. American Society of Hematology (49)
  3. Nature Publishing Group (13)
  4. American Society of Clinical Oncology (4)
  5. John Wiley & Sons, Inc. (3)
  6. American Association for the Advancement of Science (2)

More Publishers

Results (138)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Addition of tocilizumab to cyclosporine/ MMF for acute graft-vs-host disease (aGVHD) prophylaxis in adult double unit cord blood transplant (dCBT) recipients: Promising preliminary results of a phase II clinical trial
    Meeting Abstract

    Politikos, I.; Maloy, M. A.; Devlin, S. M.; Naputo, K.; Bhatt, V.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Hanash, A. M.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Double-unit cord blood (CB) transplantation (dCBT) supplemented with haplo-identical CD34+ cells may be associated with enhanced neutrophil recovery but successful myeloid bridging is strongly influenced by haplo CD34+ cell dose and haplo-winning CB unit HLA-match
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Mazis, C.; Maloy, M. A.; Naputo, K.; Afuye, A.; Avecilla, S. T.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Engrafting unit-recipient HLA-allele mismatch is not associated with an increased risk of transplant-related mortality (TRM) or inferior progression-free survival (PFS) after double unit cord blood (CB) transplantation (dCBT) in adults with hematologic malignancies
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Maloy, M. A.; Mazis, C.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Avecilla, S. T.; Castro-Malaspina, H.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Multicenter microbiota analysis indicates that pre-HCT microbiota injury is prevalent across geography and predicts poor overall survival
    Meeting Abstract

    Peled, J. U.; Gomes, A.; Stein-Thoeringer, C.; Slingerland, J.; Slingerland, A. E.; Weber, D.; Markey, K. A.; Smith, M.; Ponce, D. M.; Clurman, A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Impact of pre-transplant measurable residual disease on relapse incidence and progression-free survival in older AML/MDS patients following allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Perales, M. A.; Papadopoulos, E. B.; Castro-Malaspina, H.; Gyurkocza, B.; Shaffer, B. C.; Tamari, R.; Tallman, M.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Microbiota injury in auto-HCT is frequent, occurs across geography, and is comparable to that observed in allo-HCT
    Meeting Abstract

    Khan, N.; Peled, J. U.; Gomes, A.; Devlin, S. M.; Rondon Clavo, C.; Clurman, A.; Slingerland, J.; Slingerland, A. E.; Maloy, M. A.; Sung, A. D.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Rapid reduction of peripheral blasts in older patients with refractory acute myeloid leukemia (AML) using reinduction with single agent anti-CD45 targeted iodine ((131)I) apamistamab [lomab-B] radioimmunotherapy in the phase III SIERRA trial
    Meeting Abstract

    Tomlinson, B. K.; Reddy, V.; Berger, M. S.; Spross, J.; Lichtenstein, R.; Gyurkocza, B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Impact of geriatric vulnerability on outcomes of older patients in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Flynn, J.; Jakubowski, A. A.; Shahrokni, A.; Dahi, P.; Perales, M. A.; Sanchez-Escamilla, M.; Tamari, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Rapid reduction of peripheral blasts in older patients with refractory acute myeloid leukemia (AML) using re-induction with single agent anti-CD45 targeted iodine ((131)I) apamistamab [Iomab-B] radioimmunotherapy in the phase III SIERRA trial
    Meeting Abstract

    Tomlinson, B. K.; Reddy, V.; Berger, M. S.; Spross, J.; Lichtenstein, R.; Gyurkocza, B.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Immune cytopenias after ex vivo CD34+-selected allogeneic hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Hsu, M.; Jakubowski, A. A.; Shah, G. L.; Cho, C.; Maloy, M. A.; Avecilla, S. T.; Papadopoulos, E. B.; Gyurkocza, B.; Castro-Malaspina, H.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save